Logotipo do repositório
 

Publicação:
Structural changes of biocompatible neutral microemulsions stabilized by mixed surfactant containing soya phosphatidylcholine and their relationship with doxorubicin release

dc.contributor.authorFormariz, T. P. [UNESP]
dc.contributor.authorChiavacci, L. A. [UNESP]
dc.contributor.authorSarmento, V. H. V. [UNESP]
dc.contributor.authorFranzini, C. M. [UNESP]
dc.contributor.authorSilva, A. A. [UNESP]
dc.contributor.authorScarpa, M. V. [UNESP]
dc.contributor.authorSantilli, Celso Valentim [UNESP]
dc.contributor.authorEgito, E. S. T.
dc.contributor.authorOliveira, Anselmo Gomes de [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade Federal do Rio Grande do Norte (UFRN)
dc.date.accessioned2014-05-20T14:18:21Z
dc.date.available2014-05-20T14:18:21Z
dc.date.issued2008-06-01
dc.description.abstractDepending on the composition, the mixture of surfactant, oil and water, may form supramolecular aggregates with different structures which can significantly influence the drug release. In this work several microemulsion (ME) systems containing soya phosphatidylcholine (SPC) and eumulgin HRE40 (TM) (EU) as surfactant, cholesterol (O) as oil phase, and ultra-pure water as an aqueous phase were studied. MEs with and without the antitumoral drug doxorubicin (DOX) were prepared. The microstructures of the systems were characterized by photon correlation spectroscopy, rheological behavior, polarized light microscopy, small-angle X-ray scattering (SAXS) and X-ray diffraction (XRD). The results reveal that the diameter of the oil droplets was dependent on the surfactant (S) amount added to formulations. The apparent viscosity was dependent on the O/S ratio. High O/S ratio leads to the crystallization of cholesterol polymorphs phases which restricts the mobility of the DOX molecules into the ME structure. Droplets with short-range spatial correlation were formed from the ME with the low O/S ratio. The increase of the cholesterol fraction in the O/S mixture leads to the formation of ordered structures with lamellar arrangements. These different structural organizations directly influenced the drug release profiles. The in vitro release assay showed that the increase of the O/S ratio in the formulations inhibited the constant rate of DOX release. Since the DOX release ratio was directly dependent on the ratio of O/S following an exponential decay profile, this feature can be used to control the DOX release from the ME formulations. (C) 2008 Elsevier B.V. All rights reserved.en
dc.description.affiliationUNESP, Fac Ciencias Farmaceut, Dept Farmacos & Medicamentos, BR-14801902 Araraquara, SP, Brazil
dc.description.affiliationUNESP, Inst Quim, Dept Quim Fis, BR-14800900 Araraquara, SP, Brazil
dc.description.affiliationUniversidade Federal do Rio Grande do Norte (UFRN), Ctr Ciencias Saude, Dept Farmacia, BR-59010 Natal, RN, Brazil
dc.description.affiliationUnespUNESP, Fac Ciencias Farmaceut, Dept Farmacos & Medicamentos, BR-14801902 Araraquara, SP, Brazil
dc.description.affiliationUnespUNESP, Inst Quim, Dept Quim Fis, BR-14800900 Araraquara, SP, Brazil
dc.format.extent287-295
dc.identifierhttp://dx.doi.org/10.1016/j.colsurfb.2007.12.021
dc.identifier.citationColloids and Surfaces B-biointerfaces. Amsterdam: Elsevier B.V., v. 63, n. 2, p. 287-295, 2008.
dc.identifier.doi10.1016/j.colsurfb.2007.12.021
dc.identifier.issn0927-7765
dc.identifier.lattes5584298681870865
dc.identifier.orcid0000-0002-8356-8093
dc.identifier.urihttp://hdl.handle.net/11449/25524
dc.identifier.wosWOS:000256102800018
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofColloids and Surfaces B: Biointerfaces
dc.relation.ispartofjcr3.997
dc.relation.ispartofsjr1,071
dc.rights.accessRightsAcesso restritopt
dc.sourceWeb of Science
dc.subjectmicroemulsionen
dc.subjectcholesterolen
dc.subjectlamellar structuresen
dc.subjectdrug deliveryen
dc.subjectdoxorubicinen
dc.titleStructural changes of biocompatible neutral microemulsions stabilized by mixed surfactant containing soya phosphatidylcholine and their relationship with doxorubicin releaseen
dc.typeArtigopt
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
dspace.entity.typePublication
relation.isDepartmentOfPublicatione214da1b-9929-4ae9-b8fd-655e9bfeda4b
relation.isDepartmentOfPublication.latestForDiscoverye214da1b-9929-4ae9-b8fd-655e9bfeda4b
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.author.lattes9114495952533044[9]
unesp.author.lattes5584298681870865[7]
unesp.author.orcid0000-0002-0107-9940[9]
unesp.author.orcid0000-0002-8356-8093[7]
unesp.campusUniversidade Estadual Paulista (UNESP), Instituto de Química, Araraquarapt
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.departmentFármacos e Medicamentos - FCFpt
unesp.departmentFísico-Química - IQARpt

Arquivos

Licença do Pacote

Agora exibindo 1 - 2 de 2
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: